A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 634 participants.

Also called NCT02996721

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 634 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02996721
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02996721. Randomized; no masking; primary purpose treatment. Start 2017-04-03 (actual); primary completion 2025-03-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients
Acronym
TARGET-D
Condition
Death
Condition
Cerebral Vascular Accident
Condition
Heart Failure Hospitalization
Intervention (Biological)
Vitamin D3
Lead sponsor
Intermountain Health Care, Inc. (class: other)

Record details

Record id
cardio:ct-nct02996721
Content hash
1cdfbd50ffc1bb0b752ac94290693e079e59c6188af012e891d8010bd8e214cf